The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Number of biopharma venture financing deals from 2017 to 2022
Number of biopharma venture financing deals 2017-2022
This statistic displays the number of venture financing deals worldwide within the biopharmaceutical industry from 2017 to 2022. In 2022, there were 381 venture financing deals globally in the industry.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Value of pharma and biotech merger and acquisition deals 2020-2024
- Premium Statistic Total number of pharma merger and acquisition deals 2020-2024
- Premium Statistic Total value of top pharmaceutical venture financing deals 2014
- Basic Statistic 3 year average R&D cost to develop new biopharmaceutical compounds 2010-2020
- Premium Statistic Percentage return on R&D among large cap biopharma companies 2010-2020
- Premium Statistic Cost to bring large cap biopharmaceutical assets to market 2010-2020
- Basic Statistic R&D cost to develop new pharmaceutical compounds 2010-2020
- Basic Statistic Projection of top therapeutic areas by sales worldwide 2019
- Premium Statistic Average value of biopharma M&A deals worldwide 2010-2019, by industry
- Basic Statistic U.S. number of venture capital deals for oncology companies 2006-2023
About the region
10
- Basic Statistic Top global orphan drugs by revenue 2018
- Premium Statistic Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Basic Statistic Orphan drug sales worldwide by therapy category 2030
- Premium Statistic Leading pharmaceutical companies' SG&A to revenue rate 2024
- Premium Statistic Leading global pharmaceutical products by projected sales 2026
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Premium Statistic Share of global immunoglobulin therapies market 2017, by country
- Premium Statistic Value of biopharma M&A deals worldwide 2010-2019, by industry
- Premium Statistic Pharmaceutical companies by highest net margin 2014
- Premium Statistic Leading pharmaceutical companies by global anti-viral revenue 2017 and 2024
Selected statistics
10
- Premium Statistic Average peak sales forecast per new biopharmaceutical asset 2013-2025
- Premium Statistic Average R&D cost to develop new biopharma compound 2013-2025
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by companies
- Basic Statistic Number of biopharma M&A deals worldwide 2010-2019, by total transaction value
- Basic Statistic Projected top pharmaceutical companies based on sales 2023
- Premium Statistic Top U.S. pharmaceutical patent expiries by revenue 2014-2016
- Basic Statistic Projected top pharmaceutical companies based on new sales 2023
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by industry
- Premium Statistic R&D spending growth worldwide on pharmaceuticals 2019-2032
- Premium Statistic Patent expiration risk for total worldwide global Rx drug revenue 2018-2032
Other regions
10
- Premium Statistic Market share of generics in Finland 2016-2021
- Premium Statistic Pharmaceutical industry revenue in Asian major countries 2014
- Basic Statistic Pharmaceutical imports and exports in Asia 2014 by major country
- Basic Statistic Number of biosimilar drugs becoming available United States 2015-2022
- Premium Statistic Pharmacy market sales' parallel import share - European countries 2024
- Premium Statistic Pharma market value in Latin America 2021-2023
- Basic Statistic Pharmaceutical imports and exports in Africa by major country 2014
- Basic Statistic U.S. venture funding of therapeutic companies by disease type 2024
- Basic Statistic Profits of pharmaceutical company GlaxoSmithKline Consumer Nigeria 2020
- Premium Statistic Profits of the Nigerian pharmaceutical company Pharma Deko 2020
Related statistics
10
- Basic Statistic Global pharmaceutical industry by production value 2006-2018
- Premium Statistic Top 10 global pharmaceutical companies by revenue 2025
- Basic Statistic Mechanism of action in oncology pipeline worldwide 2023
- Premium Statistic Mechanism of action in obesity R&D pipeline worldwide 2024
- Premium Statistic Leading global mid and small biotech pharma risers based on share price 2022
- Premium Statistic Gene, cell, and RNA therapy startup financing quarterly Q4 2021-Q4 2025
- Premium Statistic Market revenue from type 2 diabetes pharmaceuticals by region 2012-2022
- Premium Statistic Annual revenue forecast for the global pharmaceutical market 2012-2022
- Premium Statistic Revenue forecast for global biologics market 2016-2022
- Premium Statistic Revenue shares of big pharma as of 2017, by business strategy
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Evaluate Vantage. (January 12, 2023). Number of biopharma venture financing deals from 2017 to 2022 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 28, 2026, from /statistics/314630/global-pharmaceutical-industry-venture-financing-deals/
Evaluate Vantage. "Number of biopharma venture financing deals from 2017 to 2022." Chart. January 12, 2023. ÌÇÐÄÆƽâ°æ. Accessed July 28, 2026. /statistics/314630/global-pharmaceutical-industry-venture-financing-deals/
Evaluate Vantage. (2023). Number of biopharma venture financing deals from 2017 to 2022. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 28, 2026. /statistics/314630/global-pharmaceutical-industry-venture-financing-deals/
Evaluate Vantage. "Number of Biopharma Venture Financing Deals from 2017 to 2022." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 12 Jan 2023, /statistics/314630/global-pharmaceutical-industry-venture-financing-deals/
Evaluate Vantage, Number of biopharma venture financing deals from 2017 to 2022 ÌÇÐÄÆƽâ°æ, /statistics/314630/global-pharmaceutical-industry-venture-financing-deals/ (last visited July 28, 2026)
Number of biopharma venture financing deals from 2017 to 2022 [Graph], Evaluate Vantage, January 12, 2023. [Online]. Available: /statistics/314630/global-pharmaceutical-industry-venture-financing-deals/
Advertisement